Plant-Based API Market Poised To Hit $52 Billion By 2034, Driven By Psychedelics And Cannabinoids
Plant-Based API Market Poised To Hit $52 Billion By 2034, Driven By Psychedelics And Cannabinoids
植物基础API市场预计到2034年将达到520亿美元，受致幻剂和大麻素的推动。
The global plant-based Active Pharmaceutical Ingredient (API) market is projected to grow at a steady pace, reaching a valuation of $52.1 billion by 2034, according to a new report by Future Market Insights. The industry is expected to expand at a Compound Annual Growth Rate (CAGR) of 5.6%, fueled by rising demand for natural and sustainable pharmaceutical solutions, including psychedelics and cannabis-derived compounds.
全球植物基原料药市场预计将稳步增长，到2034年估值将达到521亿。根据Future Market Insights的一份新报告，该行业预计将以5.6%的复合年增长率扩张，受到对天然和可持续药品解决方案（包括迷幻药和大麻衍生化合物）需求上升的推动。
Rising Demand For Psychedelic And Cannabis-Based Ingredients
对迷幻药和大麻基成分的需求上升
A significant driver of market growth is the increasing use of psychoactive and plant-derived substances in modern pharmacology. Psychedelics like psilocybin and cannabinoids such as CBD and THC are...
市场增长的一个重要驱动因素是精神活性植物衍生物在现代药理学中...
登录免费看全文
登录/注册
资讯热榜
更新时间